Viewing Study NCT07284134


Ignite Creation Date: 2025-12-25 @ 2:38 AM
Ignite Modification Date: 2026-01-18 @ 9:02 AM
Study NCT ID: NCT07284134
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-12-16
First Post: 2025-12-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: JS107 vs Investigator's Choice as Second-line or Later Therapy for Advanced CLDN18.2-Positive Gastricor GEJ Adenocarcinoma.
Sponsor: Shanghai Junshi Bioscience Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module